img

Global Animal Biopharma Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Animal Biopharma Market Report, History and Forecast 2024-2034, Breakdown Data by Companies, Key Regions, Types and Application

Animal Biopharma report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Animal Biopharma market is projected to reach US$ million in 2034, increasing from US$ million in 2022, with the CAGR of % during the period of 2024 to 2034. Demand from Prevention and Treatment are the major drivers for the industry.
North America, Europe and Asia Pacific are the key regions for Animal Biopharma industry. Among those areas, stimulated by rigid demand from downstream industries, Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2024 to 2034.
Globally, Animal Biopharma key companies include Boehringer Ingelheim, Invetx, CZ Vaccines, Scout Bio, Zoetis, Merck, Elanco, Virbac and Ceva, etc. Boehringer Ingelheim, Invetx, CZ Vaccines are top 3 players and held % share in total in 2022.
Animal Biopharma can be divided into Vaccine (Bacteria), Immune Serum, Antigen & Antibody and Others, etc. Vaccine (Bacteria) is the mainstream product in the market, accounting for % share globally in 2022.
Animal Biopharma is widely used in various fields, such as Prevention and Treatment, etc. Prevention provides greatest supports to the Animal Biopharma industry development. In 2022, global % share of Animal Biopharma went into Prevention filed.
Report Scope
This report, based on historical analysis (2024-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Animal Biopharma market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report



By Company


Boehringer Ingelheim
Invetx
CZ Vaccines
Scout Bio
Zoetis
Merck
Elanco
Virbac
Ceva
Vetoquinol
Segment by Type
Vaccine (Bacteria)
Immune Serum
Antigen & Antibody
Others

Segment by Application


Prevention
Treatment
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries

Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia

Latin America
Mexico
Brazil

Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Animal Biopharma market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2024-2024, 2024-2034).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2024 to 2024.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Animal Biopharma introduction, etc. Animal Biopharma Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12Mr Accuracy reports’s Conclusions of Animal Biopharma market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Market Overview of Animal Biopharma
1.1 Animal Biopharma Market Overview
1.1.1 Animal Biopharma Product Scope
1.1.2 Animal Biopharma Market Status and Outlook
1.2 Global Animal Biopharma Market Size Overview by Region 2024 VS 2022 VS 2034
1.3 Global Animal Biopharma Market Size by Region (2024-2034)
1.4 Global Animal Biopharma Historic Market Size by Region (2024-2024)
1.5 Global Animal Biopharma Market Size Forecast by Region (2024-2034)
1.6 Key Regions, Animal Biopharma Market Size (2024-2034)
1.6.1 North America Animal Biopharma Market Size (2024-2034)
1.6.2 Europe Animal Biopharma Market Size (2024-2034)
1.6.3 Asia-Pacific Animal Biopharma Market Size (2024-2034)
1.6.4 Latin America Animal Biopharma Market Size (2024-2034)
1.6.5 Middle East & Africa Animal Biopharma Market Size (2024-2034)
2 Animal Biopharma Market by Type
2.1 Introduction
2.1.1 Vaccine (Bacteria)
2.1.2 Immune Serum
2.1.3 Antigen & Antibody
2.1.4 Others
2.2 Global Animal Biopharma Market Size by Type: 2024 VS 2022 VS 2034
2.2.1 Global Animal Biopharma Historic Market Size by Type (2024-2024)
2.2.2 Global Animal Biopharma Forecasted Market Size by Type (2024-2034)
2.3 Key Regions Market Size by Type
2.3.1 North America Animal Biopharma Revenue Breakdown by Type (2024-2034)
2.3.2 Europe Animal Biopharma Revenue Breakdown by Type (2024-2034)
2.3.3 Asia-Pacific Animal Biopharma Revenue Breakdown by Type (2024-2034)
2.3.4 Latin America Animal Biopharma Revenue Breakdown by Type (2024-2034)
2.3.5 Middle East and Africa Animal Biopharma Revenue Breakdown by Type (2024-2034)
3 Animal Biopharma Market Overview by Application
3.1 Introduction
3.1.1 Prevention
3.1.2 Treatment
3.2 Global Animal Biopharma Market Size by Application: 2024 VS 2022 VS 2034
3.2.1 Global Animal Biopharma Historic Market Size by Application (2024-2024)
3.2.2 Global Animal Biopharma Forecasted Market Size by Application (2024-2034)
3.3 Key Regions Market Size by Application
3.3.1 North America Animal Biopharma Revenue Breakdown by Application (2024-2034)
3.3.2 Europe Animal Biopharma Revenue Breakdown by Application (2024-2034)
3.3.3 Asia-Pacific Animal Biopharma Revenue Breakdown by Application (2024-2034)
3.3.4 Latin America Animal Biopharma Revenue Breakdown by Application (2024-2034)
3.3.5 Middle East and Africa Animal Biopharma Revenue Breakdown by Application (2024-2034)
4 Animal Biopharma Competition Analysis by Players
4.1 Global Animal Biopharma Market Size by Players (2024-2024)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Animal Biopharma as of 2022)
4.3 Date of Key Players Enter into Animal Biopharma Market
4.4 Global Top Players Animal Biopharma Headquarters and Area Served
4.5 Key Players Animal Biopharma Product Solution and Service
4.6 Competitive Status
4.6.1 Animal Biopharma Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Boehringer Ingelheim
5.1.1 Boehringer Ingelheim Profile
5.1.2 Boehringer Ingelheim Main Business
5.1.3 Boehringer Ingelheim Animal Biopharma Products, Services and Solutions
5.1.4 Boehringer Ingelheim Animal Biopharma Revenue (US$ Million) & (2024-2024)
5.1.5 Boehringer Ingelheim Recent Developments
5.2 Invetx
5.2.1 Invetx Profile
5.2.2 Invetx Main Business
5.2.3 Invetx Animal Biopharma Products, Services and Solutions
5.2.4 Invetx Animal Biopharma Revenue (US$ Million) & (2024-2024)
5.2.5 Invetx Recent Developments
5.3 CZ Vaccines
5.3.1 CZ Vaccines Profile
5.3.2 CZ Vaccines Main Business
5.3.3 CZ Vaccines Animal Biopharma Products, Services and Solutions
5.3.4 CZ Vaccines Animal Biopharma Revenue (US$ Million) & (2024-2024)
5.3.5 Scout Bio Recent Developments
5.4 Scout Bio
5.4.1 Scout Bio Profile
5.4.2 Scout Bio Main Business
5.4.3 Scout Bio Animal Biopharma Products, Services and Solutions
5.4.4 Scout Bio Animal Biopharma Revenue (US$ Million) & (2024-2024)
5.4.5 Scout Bio Recent Developments
5.5 Zoetis
5.5.1 Zoetis Profile
5.5.2 Zoetis Main Business
5.5.3 Zoetis Animal Biopharma Products, Services and Solutions
5.5.4 Zoetis Animal Biopharma Revenue (US$ Million) & (2024-2024)
5.5.5 Zoetis Recent Developments
5.6 Merck
5.6.1 Merck Profile
5.6.2 Merck Main Business
5.6.3 Merck Animal Biopharma Products, Services and Solutions
5.6.4 Merck Animal Biopharma Revenue (US$ Million) & (2024-2024)
5.6.5 Merck Recent Developments
5.7 Elanco
5.7.1 Elanco Profile
5.7.2 Elanco Main Business
5.7.3 Elanco Animal Biopharma Products, Services and Solutions
5.7.4 Elanco Animal Biopharma Revenue (US$ Million) & (2024-2024)
5.7.5 Elanco Recent Developments
5.8 Virbac
5.8.1 Virbac Profile
5.8.2 Virbac Main Business
5.8.3 Virbac Animal Biopharma Products, Services and Solutions
5.8.4 Virbac Animal Biopharma Revenue (US$ Million) & (2024-2024)
5.8.5 Virbac Recent Developments
5.9 Ceva
5.9.1 Ceva Profile
5.9.2 Ceva Main Business
5.9.3 Ceva Animal Biopharma Products, Services and Solutions
5.9.4 Ceva Animal Biopharma Revenue (US$ Million) & (2024-2024)
5.9.5 Ceva Recent Developments
5.10 Vetoquinol
5.10.1 Vetoquinol Profile
5.10.2 Vetoquinol Main Business
5.10.3 Vetoquinol Animal Biopharma Products, Services and Solutions
5.10.4 Vetoquinol Animal Biopharma Revenue (US$ Million) & (2024-2024)
5.10.5 Vetoquinol Recent Developments
6 North America
6.1 North America Animal Biopharma Market Size by Country (2024-2034)
6.2 United States
6.3 Canada
7 Europe
7.1 Europe Animal Biopharma Market Size by Country (2024-2034)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Animal Biopharma Market Size by Region (2024-2034)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Animal Biopharma Market Size by Country (2024-2034)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Animal Biopharma Market Size by Country (2024-2034)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Animal Biopharma Market Dynamics
11.1 Animal Biopharma Industry Trends
11.2 Animal Biopharma Market Drivers
11.3 Animal Biopharma Market Challenges
11.4 Animal Biopharma Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List

List of Figure

List of Tables
Table 1. Global Market Animal Biopharma Market Size (US$ Million) Comparison by Region 2024 VS 2022 VS 2034
Table 2. Global Animal Biopharma Market Size by Region (2024-2024) & (US$ Million)
Table 3. Global Animal Biopharma Market Size Share by Region (2024-2024)
Table 4. Global Animal Biopharma Forecasted Market Size by Region (2024-2034) & (US$ Million)
Table 5. Global Animal Biopharma Forecasted Market Size Share by Region (2024-2034)
Table 6. Global Animal Biopharma Market Size (US$ Million) by Type: 2024 VS 2022 VS 2034
Table 7. Global Animal Biopharma Market Size by Type (2024-2024) & (US$ Million)
Table 8. Global Animal Biopharma Revenue Market Share by Type (2024-2024)
Table 9. Global Animal Biopharma Forecasted Market Size by Type (2024-2034) & (US$ Million)
Table 10. Global Animal Biopharma Revenue Market Share by Type (2024-2034)
Table 11. North America Animal Biopharma Revenue by Type (2024-2024) & (US$ Million)
Table 12. North America Animal Biopharma Revenue by Type (2024-2034) & (US$ Million)
Table 13. Europe Animal Biopharma Revenue by Type (2024-2024) & (US$ Million)
Table 14. Europe Animal Biopharma Revenue by Type (2024-2034) & (US$ Million)
Table 15. Asia-Pacific Animal Biopharma Revenue by Type (2024-2024) & (US$ Million)
Table 16. Asia-Pacific Animal Biopharma Revenue by Type (2024-2034) & (US$ Million)
Table 17. Latin America Animal Biopharma Revenue by Type (2024-2024) & (US$ Million)
Table 18. Latin America Animal Biopharma Revenue by Type (2024-2034) & (US$ Million)
Table 19. Middle East and Africa Animal Biopharma Revenue by Type (2024-2024) & (US$ Million)
Table 20. Middle East and Africa Animal Biopharma Revenue by Type (2024-2034) & (US$ Million)
Table 21. Global Animal Biopharma Market Size (US$ Million) by Application: 2024 VS 2022 VS 2034
Table 22. Global Animal Biopharma Market Size by Application (2024-2024) & (US$ Million)
Table 23. Global Animal Biopharma Revenue Market Share by Application (2024-2024)
Table 24. Global Animal Biopharma Forecasted Market Size by Application (2024-2034) & (US$ Million)
Table 25. Global Animal Biopharma Revenue Market Share by Application (2024-2034)
Table 26. North America Animal Biopharma Revenue by Application (2024-2024) & (US$ Million)
Table 27. North America Animal Biopharma Revenue by Application (2024-2034) & (US$ Million)
Table 28. Europe Animal Biopharma Revenue by Application (2024-2024) & (US$ Million)
Table 29. Europe Animal Biopharma Revenue by Application (2024-2034) & (US$ Million)
Table 30. Asia-Pacific Animal Biopharma Revenue by Application (2024-2024) & (US$ Million)
Table 31. Asia-Pacific Animal Biopharma Revenue by Application (2024-2034) & (US$ Million)
Table 32. Latin America Animal Biopharma Revenue by Application (2024-2024) & (US$ Million)
Table 33. Latin America Animal Biopharma Revenue by Application (2024-2034) & (US$ Million)
Table 34. Middle East and Africa Animal Biopharma Revenue by Application (2024-2024) & (US$ Million)
Table 35. Middle East and Africa Animal Biopharma Revenue by Application (2024-2034) & (US$ Million)
Table 36. Global Animal Biopharma Revenue (US$ Million) by Players (2024-2024)
Table 37. Global Animal Biopharma Revenue Market Share by Players (2024-2024)
Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Animal Biopharma as of 2022)
Table 39. Date of Key Players Enter into Animal Biopharma Market
Table 40. Global Animal Biopharma Key Players Headquarters and Area Served
Table 41. Animal Biopharma Product Solution and Service
Table 42. Global Animal Biopharma Players Market Concentration Ratio (CR5 and HHI)
Table 43. Mergers & Acquisitions, Expansion Plans
Table 44. Boehringer Ingelheim Basic Information List
Table 45. Boehringer Ingelheim Description and Business Overview
Table 46. Boehringer Ingelheim Animal Biopharma Products, Services and Solutions
Table 47. Revenue (US$ Million) in Animal Biopharma Business of Boehringer Ingelheim (2024-2024)
Table 48. Boehringer Ingelheim Recent Developments
Table 49. Invetx Basic Information List
Table 50. Invetx Description and Business Overview
Table 51. Invetx Animal Biopharma Products, Services and Solutions
Table 52. Revenue (US$ Million) in Animal Biopharma Business of Invetx (2024-2024)
Table 53. Invetx Recent Developments
Table 54. CZ Vaccines Basic Information List
Table 55. CZ Vaccines Description and Business Overview
Table 56. CZ Vaccines Animal Biopharma Products, Services and Solutions
Table 57. Revenue (US$ Million) in Animal Biopharma Business of CZ Vaccines (2024-2024)
Table 58. CZ Vaccines Recent Developments
Table 59. Scout Bio Basic Information List
Table 60. Scout Bio Description and Business Overview
Table 61. Scout Bio Animal Biopharma Products, Services and Solutions
Table 62. Revenue (US$ Million) in Animal Biopharma Business of Scout Bio (2024-2024)
Table 63. Scout Bio Recent Developments
Table 64. Zoetis Basic Information List
Table 65. Zoetis Description and Business Overview
Table 66. Zoetis Animal Biopharma Products, Services and Solutions
Table 67. Revenue (US$ Million) in Animal Biopharma Business of Zoetis (2024-2024)
Table 68. Zoetis Recent Developments
Table 69. Merck Basic Information List
Table 70. Merck Description and Business Overview
Table 71. Merck Animal Biopharma Products, Services and Solutions
Table 72. Revenue (US$ Million) in Animal Biopharma Business of Merck (2024-2024)
Table 73. Merck Recent Developments
Table 74. Elanco Basic Information List
Table 75. Elanco Description and Business Overview
Table 76. Elanco Animal Biopharma Products, Services and Solutions
Table 77. Revenue (US$ Million) in Animal Biopharma Business of Elanco (2024-2024)
Table 78. Elanco Recent Developments
Table 79. Virbac Basic Information List
Table 80. Virbac Description and Business Overview
Table 81. Virbac Animal Biopharma Products, Services and Solutions
Table 82. Revenue (US$ Million) in Animal Biopharma Business of Virbac (2024-2024)
Table 83. Virbac Recent Developments
Table 84. Ceva Basic Information List
Table 85. Ceva Description and Business Overview
Table 86. Ceva Animal Biopharma Products, Services and Solutions
Table 87. Revenue (US$ Million) in Animal Biopharma Business of Ceva (2024-2024)
Table 88. Ceva Recent Developments
Table 89. Vetoquinol Basic Information List
Table 90. Vetoquinol Description and Business Overview
Table 91. Vetoquinol Animal Biopharma Products, Services and Solutions
Table 92. Revenue (US$ Million) in Animal Biopharma Business of Vetoquinol (2024-2024)
Table 93. Vetoquinol Recent Developments
Table 94. North America Animal Biopharma Market Size by Country (2024-2024) & (US$ Million)
Table 95. North America Animal Biopharma Market Size by Country (2024-2034) & (US$ Million)
Table 96. Europe Animal Biopharma Market Size by Country (2024-2024) & (US$ Million)
Table 97. Europe Animal Biopharma Market Size by Country (2024-2034) & (US$ Million)
Table 98. Asia-Pacific Animal Biopharma Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 99. Asia-Pacific Animal Biopharma Market Size by Region (2024-2024) & (US$ Million)
Table 100. Asia-Pacific Animal Biopharma Market Size by Region (2024-2034) & (US$ Million)
Table 101. Asia-Pacific Animal Biopharma Market Share by Region (2024-2024)
Table 102. Asia-Pacific Animal Biopharma Market Share by Region (2024-2034)
Table 103. Latin America Animal Biopharma Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 104. Latin America Animal Biopharma Market Size by Country (2024-2024) & (US$ Million)
Table 105. Latin America Animal Biopharma Market Size by Country (2024-2034) & (US$ Million)
Table 106. Middle East & Africa Animal Biopharma Market Size Growth Rate (CAGR) by Region (US$ Million): 2024 VS 2022 VS 2034
Table 107. Middle East & Africa Animal Biopharma Market Size by Country (2024-2024) & (US$ Million)
Table 108. Middle East & Africa Animal Biopharma Market Size by Country (2024-2034) & (US$ Million)
Table 109. Animal Biopharma Market Trends
Table 110. Animal Biopharma Market Drivers
Table 111. Animal Biopharma Market Challenges
Table 112. Animal Biopharma Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Animal Biopharma Market Size Year-over-Year 2024-2034 & (US$ Million)
Figure 2. Global Animal Biopharma Market Size (US$ Million), 2024 VS 2022 VS 2034
Figure 3. Global Animal Biopharma Market Share by Regions: 2022 VS 2034
Figure 4. Global Animal Biopharma Forecasted Market Size Share by Region (2024-2034)
Figure 5. North America Animal Biopharma Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 6. Europe Animal Biopharma Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 7. Asia-Pacific Animal Biopharma Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 8. Latin America Animal Biopharma Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 9. Middle East & Africa Animal Biopharma Market Size Growth Rate (2024-2034) & (US$ Million)
Figure 10. Product Picture of Vaccine (Bacteria)
Figure 11. Global Vaccine (Bacteria) Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 12. Product Picture of Immune Serum
Figure 13. Global Immune Serum Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 14. Product Picture of Antigen & Antibody
Figure 15. Global Antigen & Antibody Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 16. Product Picture of Others
Figure 17. Global Others Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 18. Global Animal Biopharma Market Size Share by Type: 2022 & 2034
Figure 19. North America Animal Biopharma Revenue Market Share by Type (2024-2034)
Figure 20. Europe Animal Biopharma Revenue Market Share by Type (2024-2034)
Figure 21. Asia-Pacific Animal Biopharma Revenue Market Share by Type (2024-2034)
Figure 22. Latin America Animal Biopharma Revenue Market Share by Type (2024-2034)
Figure 23. Middle East and Africa Animal Biopharma Revenue Market Share by Type (2024-2034)
Figure 24. Prevention Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 25. Treatment Market Size (US$ Million) & YoY Growth (2024-2034)
Figure 26. Global Animal Biopharma Market Size Share by Application: 2022 & 2034
Figure 27. North America Animal Biopharma Revenue Market Share by Application (2024-2034)
Figure 28. Europe Animal Biopharma Revenue Market Share by Application (2024-2034)
Figure 29. Asia-Pacific Animal Biopharma Revenue Market Share by Application (2024-2034)
Figure 30. Latin America Animal Biopharma Revenue Market Share by Application (2024-2034)
Figure 31. Middle East and Africa Animal Biopharma Revenue Market Share by Application (2024-2034)
Figure 32. Animal Biopharma Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2024 VS 2022
Figure 33. Global Top 5 and Top 10 Players Animal Biopharma Market Share in 2022
Figure 34. North America Animal Biopharma Market Share by Country (2024-2034)
Figure 35. United States Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 36. Canada Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 37. Germany Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 38. France Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 39. U.K. Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 40. Italy Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 41. Russia Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 42. Nordic Countries Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 43. Asia-Pacific Animal Biopharma Market Share by Region (2024-2034)
Figure 44. China Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 45. Japan Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 46. South Korea Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 47. Southeast Asia Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 48. India Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 49. Australia Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 50. Latin America Animal Biopharma Market Share by Country (2024-2034)
Figure 51. Mexico Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 52. Brazil Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 53. Middle East & Africa Animal Biopharma Market Share by Country (2024-2034)
Figure 54. Turkey Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 55. Saudi Arabia Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 56. UAE Animal Biopharma Market Size (2024-2034) & (US$ Million)
Figure 57. Bottom-up and Top-down Approaches for This Report